AAV1-BDNF

N/A

Report date: 2025/06/11 11:23:49

Base Information

Drug NameAAV1-BDNF
Drug Alias NameBDNF gene therapy (MeiraGTx)AAV1-BDNF gene therapy (MeiraGTx)AAV-BDNFAAV1-BDNF
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vectorCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAppetite suppressantBrain-derived neurotrophic factor expression stimulants
TargetsBrain-derived neurotrophic factor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMeiragtx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiragtx Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A